Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
4.08 USD +4.62% Intraday chart for Fate Therapeutics, Inc. +0.49% +9.09%
05-10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
05-10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FATE Stock
  4. News Fate Therapeutics, Inc.
  5. MarketScreener Editorial Features